Neutrophil gelatinase-associated lipocalin for predicting clinical stability in patients with community-acquired pneumonia
R. Lin (GuangZhou, China), M. Xue (GuangZhou, China), T. Zhang (Macau, China), Y. Zeng (GuangZhou, China), W. Cao (GuangZhou, China), S. Wu (GuangZhou, China), M. Liu (GuangZhou, China), N. Li (GuangZhou, China), P. Zheng (GuangZhou, China), H. Hu (GuangZhou, China), C. Huang (Macau, China), B. Sun (GuangZhou, China)
Source: International Congress 2022 – Pneumonia
Session: Pneumonia
Session type: Thematic Poster
Number: 4041
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Lin (GuangZhou, China), M. Xue (GuangZhou, China), T. Zhang (Macau, China), Y. Zeng (GuangZhou, China), W. Cao (GuangZhou, China), S. Wu (GuangZhou, China), M. Liu (GuangZhou, China), N. Li (GuangZhou, China), P. Zheng (GuangZhou, China), H. Hu (GuangZhou, China), C. Huang (Macau, China), B. Sun (GuangZhou, China). Neutrophil gelatinase-associated lipocalin for predicting clinical stability in patients with community-acquired pneumonia. 4041
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|